Idexx Laboratories | Des Atouts



Assets Changement Date
Abbott USD 81.41B 7.06B 2024-12
Align Technology USD 6.21B 151.37M 2024-12
Dentsply International USD 5.75B 873M 2024-12
Dexcom USD 6.48B 130.7M 2024-12
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Fujifilm JPY 5.28T 384.93B 2024-12
Globus Medical USD 5.25B 165.71M 2024-12
Henry Schein USD 10.22B 387M 2024-12
Hologic USD 8.73B 427.3M 2024-12
Idexx Laboratories USD 3.29B 57.32M 2024-12
Insulet USD 3.09B 62.3M 2024-12
Integra LifeSciences USD 4.04B 28.38M 2024-12
Intuitive Surgical USD 18.74B 999.8M 2024-12
Masimo USD 2.63B 462.1M 2024-12
Neogen USD 4.04B 17.76M 2025-02
Patterson Companies USD 2.83B 13.02M 2025-01
ResMed USD 7.14B 81.08M 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
Steris USD 10.01B 233.78M 2024-12
Tandem Diabetes Care USD 967.66M 9.93M 2024-12
Teleflex USD 7.1B 388.38M 2024-12
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12
Zoetis USD 14.24B 120M 2024-12



Idexx Laboratories Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.